d4a5a598c2410dddc7dbc546b392f291
DEI-Glaucoma-Conferenc-Header-2024-1200-x-400-px_v2

2nd Annual Doheny-UCLA International

Retina Symposium

 

January 27, 2024

7 AM – 4:30 p.m.

 

About the Course:

This course is tailored to update practicing ophthalmologists and related health care specialists on recent advances and controversies in the management of a variety of posterior segment disorders. The desired result is to gain and develop an evidence based approach to the management of patients with retinal disease.

Featured Keynotes

“Understanding the Discord between Pragmatic Measures of Retinal Function and Progression of Geographic Atrophy ” and
“Fibrosis an Unmet Need in the Long-Term Management of nAMD”

Usha Chakravarthy, MD, PhD, CBE

Honorary and Emerita Professor of Ophthalmology and Vision Science
Queen’s University of Belfast
Institute of Clinical Science
Royal Victoria Hospital, Belfast BT12 6BA, UK

“How Careful Clinical Examination Skills can lead to Novel Retinal Diagnoses” and “Clinical Impact of the DRCR Retina Network”

Lee M. Jampol, MD

Louis Feinberg, MD, Professor of Ophthalmology
Northwestern Medicine, Feinberg School of Medicine
Chicago, IL

Conference Presentations

Explore the program here

“Wet AMD and Dry AMD – What is in the pipeline?”

David Boyer, MD

Retinal Specialist and Vitreoretinal Surgeon
Retina Vitreous Associates Medical Group

 

“Three Dimensional Ophthalmic Ultrasonography using existing Ultrasound Probes”

Andrew Browne, MD, PhD

Assistant Professor of Ophthalmology

UC Irvine School of Medicine

Gavin Herbert Eye Institute

“Prohylaxsis of Wet AMD: The PREVENT Study Results”

Clement K. Chan, MD, FACS

President and Medical Director

Southern California Desert Retina Consultants

Professor of Ophthalmology

Loma Linda University

“Microperimetric Functional Correlates of Structural Biomarkers in Nonneovascular AMD”

Giulia Corradetti, MD

Doheny Scientist
Doheny Image Reading and Research Lab (DIRRL), Doheny Eye Institute

 

“Evaluation and Management of Ocular Hypotony”

Kirk Hou, MD, PhD

Course Co-Director

Assistant Professor

David Geffen School of Medicine UCLA

Doheny Eye Institute

Talk 1: Long term results of anti-VEGF for Retinal Vein Occlusion

Talk 2: Data Update on some of the Newest FDA Approved Injectables for Disease of the Retina

Michael Ip, MD

Gavin S. Herbert Endowed Chair for Macular Degeneration
Professor of Ophthalmology
David Geffen School of Medicine UCLA
Medical Director, Doheny Image Reading Center
Doheny Eye Institute

“Retinal Progenitor Cells for the Treatment of Retinitis Pigmentosa”

Baruch Kuppermann, MD, PhD

Steinert Endowed Professor and Chair

Department of Ophthalmology

UC Irvine School of Medicine

Director, Gavin Herbert Eye Institute

“Update on the Diagnosis and Management of Intraocular Lymphoma”

Colin A. McCannel, MD

Professor of Ophthalmology

David Geffen School of Medicine UCLA

UCLA Stein Eye Institute

“Novel Vision-Sparing Strategies for Uveal Melanoma Patients”

Tara McCannel, MD, PhD

Director, Ophthalmic Oncology Center

Professor of Ophthalmology

David Geffen School of Medicine UCLA

UCLA Stein Eye Institute

“Engineering New Models for Healthcare Delivery”

Bobeck Modjtahedi, MD, MBA

Vitreoretinal Surgeon

Southern California Medical Group

Director, Eye Monitoring Center

Kaiser Permanente Southern California, Georgia, Colorado, and Hawaii

“Vitreoretinal Interface Disorders”

Andrew Moshfeghi, MD, MBA

Associate Professor of Ophthalmology

Director of Clinical Trials

Medical Director

Keck School of Medicine of USC

USC Roski Eye Institute

“Surgical Outcomes and Predictors of Success in Diabetic Combined Tractional and Rhegmatogenous Retinal Detachments”

Pradeep S. Prasad, MD, MBA

Health Science Associate Professor of Ophthalmology

Assistant Chief, Retina Division of Ophthalmology

Harbor UCLA Medical Center

David Geffen School of Medicine UCLA

UCLA Stein Eye Institute

“OCT Risk Factors for Development of Atrophy in AMD”

SriniVas Sadda, MD

Director, Artificial Intelligence & Imaging Research
Professor of Ophthalmology
David Geffen School of Medicine UCLA
Doheny Eye Institute

“Treatment of Neovascular AMD: How Completely Do We Need to Treat Fluid?”

David Sarraf, MD

Professor of Ophthalmology

Retinal Disorders and Ophthalmic Genetic Division

David Geffen School of Medicine UCLA

UCLA Stein Eye Institute

“Secondary IOL Techniques for the Retinal Surgeon”

Jay Sridhar, MD

Chief of Ophthalmology

Los Angeles County Department of Health Services

UCLA Olive View Medical Center

Panel 1: Geographic Atrophy: Past, Present and Future

Moderator: Vas Sadda, MD

Panelists: Doctors Boyer, Chakravarthy, Chan, C. McCannel

Panel 2: Which Drugs to use for which Retinal Condition: How do we choose?

Moderator: Michael Ip, MD

Panelists: Doctors Jampol, Modjtahedi, Browne, Sarraf

Course Directors

Michael Ip, MD

Gavin S. Herbert Endowed Chair for Macular Degeneration

Professor of Ophthalmology

David Geffen School of Medicine UCLA

Medical Director, Doheny Image Reading Center

Doheny Eye Institute

Kirk-Hou-MD-PHD

Kirk Hou, MD, PhD

Course Co-Director

Assistant Professor

David Geffen School of Medicine UCLA

Doheny Eye Institute

REGISTER TODAY!

Doheny Eye Institute acknowledges with gratitude the following organizations for their participation:

Educational Grantors:
Genentech, a member of the Roche Group 
Iveric Bio, An Astellas Company   •   Regeneron
REGENXBIO Inc.   •   Zeiss

Exhibitors:
Alcon   •   Alimera Sciences   •   Apellis Pharmaceuticals 
Dutch Ophthalmic USA   •   Coherus BioSciences

Stay in touch!

We hope to see you at the upcoming CME Conference. Please reach out if you have any questions.